Your browser doesn't support javascript.
loading
Comparative randomised active drug controlled clinical trial of a herbal eye drop in computer vision syndrome.
J Indian Med Assoc ; 2005 Jul; 103(7): 397-8
Article in English | IMSEAR | ID: sea-103691
ABSTRACT
A comparative double-blind placebo-controlled clinical trial of a herbal eye drop (itone) was conducted to find out its efficacy and safety in 120 patients with computer vision syndrome. Patients using computers for more than 3 hours continuously per day having symptoms of watering, redness, asthenia, irritation, foreign body sensation and signs of conjunctival hyperaemia, corneal filaments and mucus were studied. One hundred and twenty patients were randomly given either placebo, tears substitute (tears plus) or itone in identical vials with specific code number and were instructed to put one drop four times daily for 6 weeks. Subjective and objective assessments were done at bi-weekly intervals. In computer vision syndrome both subjective and objective improvements were noticed with itone drops. Itone drop was found significantly better than placebo (p<0.01) and almost identical results were observed with tears plus (difference was not statistically significant). Itone is considered to be a useful drug in computer vision syndrome.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Ophthalmic Solutions / Vision Disorders / Female / Humans / Male / Computers / Double-Blind Method / Analysis of Variance / Treatment Outcome / Statistics, Nonparametric Type of study: Controlled clinical trial Language: English Journal: J Indian Med Assoc Year: 2005 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Ophthalmic Solutions / Vision Disorders / Female / Humans / Male / Computers / Double-Blind Method / Analysis of Variance / Treatment Outcome / Statistics, Nonparametric Type of study: Controlled clinical trial Language: English Journal: J Indian Med Assoc Year: 2005 Type: Article